Evidence map›Paper›PMID 19073871›Full record

ArticleJournal of clinical microbiology2009

Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland.

Tuula Siljander, Outi Lyytikäinen, Susanna Vähäkuopus, Petrus Säilä, Jari Jalava, Jaana Vuopio-Varkila

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
  3. Review
  4. Distribution of emm types in invasive and non-invasive group A and G streptococci.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  5. Streptococcus pyogenes bacteraemia, emm types and superantigen profiles.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  6. Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2010
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tuula SiljanderDepartment of Bacterial and Inflammatory Diseases, Hospital Bacteria Laboratory, National Public Health Institute, Helsinki, Finland. tuula.siljander@thl.fi
Outi Lyytikäinen
Susanna Vähäkuopus
Petrus Säilä
Jari Jalava
Jaana Vuopio-Varkila
University of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From 2005 to 2007, in Finland, the incidence of invasive Streptococcus pyogenes disease increased sharply, partly due to the uncommon emm84 gene becoming more prevalent from 2006 onwards. The overall case fatality rate of infections caused by strains carrying emm84 was not significantly different than that of infections caused by other types (7% versus 10%, respectively; P = 0.50).

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsFinlandHumansIncidenceStreptococcal InfectionsStreptococcus pyogenesAntigens, BacterialBacterial Outer Membrane ProteinsCarrier Proteinsstreptococcal M protein

Identifiers

PMID19073871
PMCPMC2643675
OpenAlexW2136456070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.